| Gilead Sciences, Inc. | 37,039 | US$4.98M | 7.4% |
| Vertex Pharmaceuticals Incorporated | 11,104 | US$4.97M | 7.4% |
| Amgen Inc. | 14,213 | US$4.79M | 7.1% |
| Regeneron Pharmaceuticals, Inc. | 5,570 | US$3.42M | 5.1% |
| Alnylam Pharmaceuticals, Inc. | 7,110 | US$2.15M | 3.2% |
| Revolution Medicines, Inc. | 10,624 | US$1.67M | 2.5% |
| Biogen Inc. | 7,868 | US$1.54M | 2.3% |
| Illumina, Inc. | 8,197 | US$1.34M | 2.0% |
| United Therapeutics Corporation | 2,350 | US$1.31M | 1.9% |
| Royalty Pharma Plc | 22,968 | US$1.28M | 1.9% |
| Argenx Se | 1,521 | US$1.27M | 1.9% |
| Insmed Incorporated | 11,556 | US$1.24M | 1.8% |
| Roivant Sciences Ltd. | 38,370 | US$1.15M | 1.7% |
| Incyte Corporation | 10,669 | US$1.03M | 1.5% |
| Viatris Inc. | 61,728 | US$1M | 1.5% |
| Moderna, Inc. | 21,173 | US$999K | 1.5% |
| Guardant Health, Inc. | 7,032 | US$912K | 1.4% |
| Neurocrine Biosciences, Inc. | 5,381 | US$852K | 1.3% |
| Jazz Pharmaceuticals Plc | 3,300 | US$780K | 1.2% |
| Ascendis Pharma A/s | 3,301 | US$740K | 1.1% |
| Summit Therapeutics Inc. | 41,569 | US$729K | 1.1% |
| Exelixis, Inc. | 13,923 | US$703K | 1.0% |
| Bridgebio Pharma, Inc. | 10,393 | US$689K | 1.0% |
| Medpace Holdings, Inc. | 1,522 | US$681K | 1.0% |
| Ionis Pharmaceuticals, Inc. | 8,856 | US$677K | 1.0% |
| Axsome Therapeutics, Inc. | 2,742 | US$643K | 0.95% |
| Madrigal Pharmaceuticals, Inc. | 1,230 | US$612K | 0.91% |
| Biomarin Pharmaceutical Inc. | 10,311 | US$591K | 0.88% |
| Arrowhead Pharmaceuticals, Inc. | 7,507 | US$585K | 0.87% |
| Sanofi Sa | 6,586 | US$573K | 0.85% |
| Praxis Precision Medicines, Inc. | 1,493 | US$523K | 0.78% |
| Cytokinetics, Incorporated | 6,597 | US$506K | 0.75% |
| Beone Medicines Ltd. Class A | 1,714 | US$493K | 0.73% |
| Krystal Biotech, Inc. | 1,567 | US$484K | 0.72% |
| Tempus Ai, Inc. | 9,314 | US$470K | 0.70% |
| Abivax Sa | 3,294 | US$437K | 0.65% |
| Nuvalent, Inc. | 3,923 | US$433K | 0.64% |
| Halozyme Therapeutics, Inc. | 6,327 | US$421K | 0.62% |
| Immunitybio, Inc. | 55,119 | US$414K | 0.62% |
| Vaxcyte, Inc. | 7,716 | US$397K | 0.59% |
| Alkermes Plc | 8,934 | US$377K | 0.56% |
| Immunovant, Inc. | 10,912 | US$363K | 0.54% |
| Kymera Therapeutics, Inc. | 4,377 | US$356K | 0.53% |
| Protagonist Therapeutics, Inc. | 3,421 | US$341K | 0.51% |
| Mirum Pharmaceuticals, Inc. | 3,235 | US$328K | 0.49% |
| Ptc Therapeutics, Inc. | 4,433 | US$327K | 0.49% |
| Rhythm Pharmaceuticals, Inc. | 3,661 | US$323K | 0.48% |
| Spyre Therapeutics, Inc. | 4,207 | US$309K | 0.46% |
| Cogent Biosciences, Inc. | 8,702 | US$304K | 0.45% |
| Crispr Therapeutics Ag | 5,136 | US$289K | 0.43% |
| Cg Oncology, Inc. | 4,527 | US$282K | 0.42% |
| Scholar Rock Holding Corporation | 5,458 | US$269K | 0.40% |
| Caris Life Sciences, Inc. | 15,091 | US$252K | 0.37% |
| Ligand Pharmaceuticals Incorporated | 1,069 | US$248K | 0.37% |
| Xenon Pharmaceuticals Inc. | 4,455 | US$244K | 0.36% |
| Indivior Pharmaceuticals, Inc. | 6,697 | US$241K | 0.36% |
| Apogee Therapeutics, Inc. | 2,933 | US$241K | 0.36% |
| Travere Therapeutics, Inc. | 4,947 | US$233K | 0.35% |
| Amneal Pharmaceuticals, Inc. | 16,863 | US$222K | 0.33% |
| Twist Bioscience Corporation | 3,287 | US$220K | 0.33% |
| Erasca, Inc. | 16,597 | US$213K | 0.32% |
| Newamsterdam Pharma Company N.v. | 6,171 | US$208K | 0.31% |
| Crinetics Pharmaceuticals, Inc. | 5,613 | US$200K | 0.30% |
| Acadia Pharmaceuticals Inc. | 9,144 | US$198K | 0.29% |
| Veracyte, Inc. | 4,260 | US$197K | 0.29% |
| Edgewise Therapeutics, Inc. | 5,751 | US$196K | 0.29% |
| Beam Therapeutics Inc. | 5,461 | US$180K | 0.27% |
| Denali Therapeutics Inc. | 8,502 | US$179K | 0.27% |
| 10x Genomics, Inc. | 6,309 | US$179K | 0.27% |
| Dyne Therapeutics, Inc. | 8,827 | US$171K | 0.25% |
| Tango Therapeutics, Inc. | 7,220 | US$159K | 0.24% |
| Oruka Therapeutics, Inc. | 2,595 | US$152K | 0.23% |
| Grail, Inc. | 2,094 | US$150K | 0.22% |
| Alumis Inc. | 6,778 | US$146K | 0.22% |
| Arcutis Biotherapeutics, Inc. | 6,650 | US$143K | 0.21% |
| Disc Medicine, Inc. | 2,046 | US$142K | 0.21% |
| Supernus Pharmaceuticals, Inc. | 3,074 | US$142K | 0.21% |
| Ideaya Biosciences, Inc. | 4,708 | US$139K | 0.21% |
| Vera Therapeutics, Inc. | 3,825 | US$136K | 0.20% |
| Tarsus Pharmaceuticals, Inc. | 2,282 | US$136K | 0.20% |
| Relay Therapeutics, Inc. | 9,582 | US$135K | 0.20% |
| Mineralys Therapeutics, Inc. | 4,243 | US$134K | 0.20% |
| Definium Therapeutics, Inc. | 5,345 | US$129K | 0.19% |
| Enliven Therapeutics, Inc. | 3,182 | US$126K | 0.19% |
| Adaptive Biotechnologies Corporation | 8,255 | US$125K | 0.19% |
| Ultragenyx Pharmaceutical Inc. | 5,180 | US$124K | 0.18% |
| Kodiak Sciences Inc | 3,273 | US$120K | 0.18% |
| Biocryst Pharmaceuticals, Inc. | 13,446 | US$120K | 0.18% |
| Kiniksa Pharmaceuticals International, Plc | 2,461 | US$119K | 0.18% |
| Aurinia Pharmaceuticals Inc | 7,129 | US$109K | 0.16% |
| Ocular Therapeutix, Inc. | 11,671 | US$105K | 0.16% |
| Pharvaris N.v. | 3,443 | US$104K | 0.15% |
| Novocure Limited | 6,072 | US$103K | 0.15% |
| Sionna Therapeutics, Inc. | 2,393 | US$102K | 0.15% |
| Adma Biologics Inc | 12,768 | US$102K | 0.15% |
| Rapport Therapeutics, Inc. | 2,574 | US$102K | 0.15% |
| Abcellera Biologics Inc. | 16,253 | US$100K | 0.15% |
| Zymeworks Inc. | 3,989 | US$100K | 0.15% |
| Sarepta Therapeutics, Inc. | 5,587 | US$99,840 | 0.15% |
| Recursion Pharmaceuticals, Inc. | 27,806 | US$99,824 | 0.15% |